e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Correlation between extracellular heat shock protein 72 and clinical parameters including exhaled oxygen level in COPD
Balázs Odler (Budapest, Hungary), Balazs Odler, Vivien Somogyi, Gabor Horvath, Veronika Müller
Source:
International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Session:
Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Session type:
Poster Discussion
Number:
3005
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Balázs Odler (Budapest, Hungary), Balazs Odler, Vivien Somogyi, Gabor Horvath, Veronika Müller. Correlation between extracellular heat shock protein 72 and clinical parameters including exhaled oxygen level in COPD. Eur Respir J 2015; 46: Suppl. 59, 3005
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Serum heat shock protein levels in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Monitoring oxidative stress during recovery from COPD exacerbations: Comparison of airway and systemic malondialdehyde levels
Source: International Congress 2016 – Airway biomarkers
Year: 2016
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Role of matrix metalloproteinase in predicting of COPD stability
Source: International Congress 2015 – COPD: notable points
Year: 2015
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Production of proinflammation cytokines and mean pulmonary arterial pressure in COPD
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014
The oxygen uptake efficiency in patients with stable COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD
Source: International Congress 2014 – Predictors
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept